8-KThe WireRoutine
Bylaw Amendment
Filed Jan 18, 2024 · 2y ago · Accession 0001171843-24-000297
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- BIOCRYST PHARMACEUTICALS INC
- Ticker
- BCRX
- CIK
- 882796
- Form type
- 8-K
- Filing date
- Jan 18, 2024
- Report date
- Jan 16, 2024
- Document
- f8k_011824.htm
- Size
- 375 KB